Cite
Monocyte NLRP3 inflammasome and interleukin-1β activation modulated by alpha-1 antitrypsin therapy in deficient individuals
MLA
Gogoi, Debananda, et al. “Monocyte NLRP3 Inflammasome and Interleukin-1β Activation Modulated by Alpha-1 Antitrypsin Therapy in Deficient Individuals.” Thorax, vol. 79, no. 9, Jan. 2024, pp. 822–33. EBSCOhost, https://doi.org/10.1136/thorax-2023-221071.
APA
Gogoi, D., Yu, H., Casey, M., Baird, R., Yusuf, A., Forde, L., O’ Brien, M. E., West, J. R., Flagg, T., McElvaney, N. G., Eden, E., Mueller, C., Brantly, M. L., Geraghty, P., & Reeves, E. P. (2024). Monocyte NLRP3 inflammasome and interleukin-1β activation modulated by alpha-1 antitrypsin therapy in deficient individuals. Thorax, 79(9), 822–833. https://doi.org/10.1136/thorax-2023-221071
Chicago
Gogoi, Debananda, Howard Yu, Michelle Casey, Rory Baird, Azeez Yusuf, Luke Forde, Michael E O’ Brien, et al. 2024. “Monocyte NLRP3 Inflammasome and Interleukin-1β Activation Modulated by Alpha-1 Antitrypsin Therapy in Deficient Individuals.” Thorax 79 (9): 822–33. doi:10.1136/thorax-2023-221071.